9-20740273-C-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001375567.1(FOCAD):c.325C>A(p.Leu109Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00107 in 1,611,708 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001375567.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FOCAD | NM_001375567.1 | c.325C>A | p.Leu109Ile | missense_variant | 5/44 | ENST00000338382.11 | NP_001362496.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FOCAD | ENST00000338382.11 | c.325C>A | p.Leu109Ile | missense_variant | 5/44 | 5 | NM_001375567.1 | ENSP00000344307 | P1 | |
FOCAD | ENST00000380249.5 | c.325C>A | p.Leu109Ile | missense_variant | 7/46 | 1 | ENSP00000369599 | P1 | ||
FOCAD | ENST00000604103.1 | n.120C>A | non_coding_transcript_exon_variant | 2/5 | 4 | |||||
FOCAD | ENST00000605031.5 | n.101C>A | non_coding_transcript_exon_variant | 2/5 | 4 |
Frequencies
GnomAD3 genomes AF: 0.000546 AC: 83AN: 151956Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000411 AC: 103AN: 250864Hom.: 0 AF XY: 0.000435 AC XY: 59AN XY: 135592
GnomAD4 exome AF: 0.00112 AC: 1635AN: 1459642Hom.: 3 Cov.: 29 AF XY: 0.00111 AC XY: 809AN XY: 726176
GnomAD4 genome AF: 0.000546 AC: 83AN: 152066Hom.: 0 Cov.: 32 AF XY: 0.000525 AC XY: 39AN XY: 74308
ClinVar
Submissions by phenotype
FOCAD-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 02, 2024 | The FOCAD c.325C>A variant is predicted to result in the amino acid substitution p.Leu109Ile. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.078% of alleles in individuals of European (Non-Finnish) descent in gnomAD. This variant is classified as a variant of uncertain significance in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/2629110/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 12, 2023 | This sequence change replaces leucine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 109 of the FOCAD protein (p.Leu109Ile). This variant is present in population databases (rs142542466, gnomAD 0.08%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with FOCAD-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Not Available"; Align-GVGD: "Not Available". The isoleucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at